Original article

Scand J Work Environ Health 2026;52(4):391-402    pdf

https://doi.org/10.5271/sjweh.4290 | Published online: 09 Apr 2026, Issue date: 01 Jul 2026

Night shift work and risk of total and site-specific cancer: results from a prospective cohort study among Chinese men

by Shen Q-M, Li Z-Y, Tan Y-T, Gao L-F, Liu D-K, Li H-L, Yang W-S, Xiang Y-B

Objective Epidemiological evidence on the association between night shift work and cancer risk remains limited and inconsistent. This study aimed to systematically investigate this association among Chinese men.

Methods This population-based prospective cohort study included 61 078 men from the Shanghai Men’s Health Study. Detailed information on night shift work was collected at baseline using a structured questionnaire. Cox regression model was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer and ten major site-specific cancers. Restricted cubic spline functions were used to characterize the dose–response associations for key metrics. Further analysis was conducted with lag periods of 5, 10, 15 and 20 years, and potential effect modification by lifestyle factors was tested.

Results During a median follow-up period of 16.1 years, 8202 incident cancer cases were identified. Participants with 11–20 years of cumulative night shift work had a higher risk of pancreatic cancer compared with never-shift workers (HR 1.59, 95% CI 1.09–2.31). This association persisted across all lag periods tested, peaking at a 15-year lag (HR 1.82, 95% CI 1.25–2.64). No significant associations were found between night shift work metrics, including night shift work experience, starting age, cumulative duration, and frequency, and the risk of total and other major site-specific cancers. No evidence of effect modification by lifestyle factors was observed.

Conclusions Night shift work was not associated with the risk of overall or some common cancers among Chinese men. However, an increased risk of pancreatic cancer was associated with intermediate-to-long-term night shift work.

This article refers to the following texts of the Journal: 2007;33(5):336-343  2014;40(5):502-510

Night shift work, characterized by work conducted during the conventional sleeping hours of the general population, is a prevalent occupational exposure worldwide. According to statistics from the International Labor Organization, 5.7–25% of the global workforce engages in night shift work (1). In China, about 17.5% of workers report working night shifts at least once a month (2). This widespread phenomenon has garnered increasing attention as a potential risk factor for a spectrum of health problems, including metabolic syndrome, diabetes, mental and autoimmune disorders, cardiovascular diseases, and cancer (3).

The International Agency for Research on Cancer (IARC) has classified night shift work as “probably carcinogenic to humans (Group 2A)” based on sufficient evidence from animal studies and limited evidence in humans (4). To date, the epidemiological findings on the association between night shift work and cancer risk remain inconclusive. Among the most frequently investigated cancer sites – namely the breast, prostate, colon, and rectum – studies have reported both positive and null associations (59). For instance, while results from the Nurses’ Health Study II (10) and Swedish Twin registry (11) reported a positive association between night shift work and breast cancer risk, other large prospective studies, such as the Million Women Study, EPIC-Oxford and UK Biobank observed no clear association (12). Such inconsistency underscores the difficulty of drawing definitive conclusions from existing evidence and highlights a critical need for further high-quality prospective cohort studies. Besides, the evidentiary value of existing cohort studies is often constrained by methodological limitations beyond their design. A key shortcoming is weak exposure assessment, which limits precise estimation (13). Some studies observed an increased risk of breast cancer was only evident among long-term night shift workers (10, 11), suggesting that crude binary exposure measures may obscure important associations. This underscores the need for cohort studies that collect detailed metrics on night shift work – such as cumulative duration and frequency of exposure – to enable more comprehensive risk assessment. Furthermore, available evidence remains disproportionately focused on the aforementioned cancer types. The potential associations between night shift work and other common cancers, including lung, liver, and pancreas have scarcely been investigated, representing a significant gap in our understanding of the full carcinogenic potential of circadian disruption.

In China, epidemiological studies on the association between night shift work and cancer are limited. Most existing studies are case–control in design, and evidence from prospective cohort studies is notably scarce (1420). Utilizing data from a large-scale, population-based prospective cohort, this study aims to systematically investigate the association between night shift work and cancer risk in the Chinese population. We examined various night shift work metrics, including ever exposure, age at starting, cumulative duration, and frequency, in relation to the risk of overall cancer and ten major site-specific cancers. We hypothesize that night shift work is associated with a higher risk of cancer. This study seeks to provide robust and detailed evidence that clarifies the impact of this common occupational exposure on cancer risk.

Methods

Study population

Participants included in this study were drawn from the Shanghai Men’s Health Study (SMHS), an ongoing, population-based prospective cohort that enrolled 61 469 men aged 40–74 years old from urban Shanghai between January 2002 and July 2006. The design and methodology of the cohort have been described previously (21). At baseline, all participants completed a structured questionnaire, which asked about demographic characteristics, lifestyle factors, dietary habits, medical history, and other relevant information. Anthropometric measurements were also obtained at baseline.

Exclusion criteria were applied as follows: (i) cancer at baseline; (ii) loss to follow-up shortly after the baseline survey; (iii) diagnosis of cancer in situ during follow-up; (iv) death from cancer with no cancer type or diagnosis date; (v) a cancer diagnosis that could not be confirmed; and (vi) without information about ever exposed to night shift work (supplementary material www.sjweh.fi/article/4290, figure S1). Altogether 61 078 men were retained in the current study.

Assessment of night shift work

At the baseline survey, all participants were asked about any history of employment involving night shift work, defined as starting work after 22:00 hours ≥3 times a month for over one year. For participants who had night shift work experience, detailed information was collected regarding the years they started and finished working night shifts, the cumulative duration of night shift work, and the average times of night shifts they worked per month. The main night shift metrics that this study focused on included night shift work experience, age at starting night shift work, cumulative duration of night shift work, and frequency of night shifts.

Covariates

Specially trained investigators collected information on age, education, income level, smoking status and alcohol consumption using a structured questionnaire in face-to-face interviews. Smoking was defined as ever smoking ≥1 cigarette per day for >6 months continuously. Alcohol consumption was defined as ever consuming alcohol ≥3 times per week for >6 months continuously. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared, and was categorized according to the Chinese classification (22) into underweight (<18.5 kg/m2), normal (18.5–23.9 kg/m2), overweight (24–27.9 kg/m2) and obese (≥28.0 kg/m2). Physical activity was assessed using a semi-quantitative physical activity questionnaire (PAQ), and total activity was computed by summing metabolic equivalent task (MET) hours per week across all activities. Our previous study demonstrated that PAQ is a reproducible and valid tool for assessing physical activity (23). An 81-item semi-quantitative food-frequency questionnaire (FFQ), which covered approximately 88.8% of commonly consumed foods in urban Shanghai during the baseline years was used to assess usual food intake. Participants reported the frequency they consumed the food or food groups over the past 12 months, as well as the average amount of consumption in liangs (50 grams/liang) per unit of time. The FFQ has been proven to have substantial reproducibility and validity (24). Daily dietary intakes were energy-adjusted using the density method and standardized to 2000 kcal. We adopted the Chinese Food Pagoda score (CHFP) score to assess adherence to the Chinese dietary guidelines (25).

Possible covariates were considered in multivariable models, including age at baseline (continuous), education (elementary school or below/ middle school/ high school/ high profession, college or above), income level (<500, 500–999, 1000–1999, and ≥2000 yuan per month), BMI (underweight/normal/overweight/obese), smoking (ever/never), alcohol consumption (ever/never), physical activity (MET hour/week, quartiles) and CHFP (quartiles). Due to the low proportion of missing data in covariates (maximum missing frequency across all variables <1.3%), missing values were imputed using medians for continuous variables and modes for categorical variables.

Assessment of outcomes

Since the baseline survey, the SMHS participants have been followed through a combination of active and passive methods. Active follow-up was conducted every 3–4 years through in-person interviews to update health status information. Passive follow-up was performed through annual record linkage to the Shanghai Cancer Registry for cancer incidence and the Shanghai Vital Statistics Registry for mortality data. Trained staff matched cohort members to registry data using unique identification numbers. Follow-up began at the date of baseline interview and continued until the date of cancer diagnosis, death, or 31 December 2020, whichever occurred first.

All diagnoses were coded according to the 9th revision of the International Classification of Diseases (ICD-9). The outcomes in this study comprised the first diagnosis of all malignant cancers (ICD-9: 140–195, 200–208) and the following 10 major site-specific malignancies: lung (ICD-9: 162), colorectum (ICD-9:153, 154), liver (ICD-9: 155), stomach (ICD-9: 151), thyroid (ICD-9: 193), esophagus (ICD-9: 150), prostate (ICD-9: 185), bladder (ICD-9: 188), pancreas (ICD-9: 157) and kidney (ICD-9: 189).

Statistical analysis

Baseline characteristics according to night shift experience were summarized as medians with interquartile ranges for continuous variables and counts with proportions for categorical variables. Mann-Whitney U test and χ2 test were performed to assess the difference between groups for continuous and categorical variables, respectively.

Detailed metrics pertaining to night shift work, including age at initiation, cumulative duration, and average monthly frequency, were visualized using box plots and compared between cancer and non-cancer groups using the Mann-Whitney U test. Cox proportional hazards regression models were used to evaluate the association between night shift metrics and cancer risk, with follow-up time as the underlying time scale. Follow-up time was calculated from the date of baseline survey until the date of outcome, death, loss to follow-up, or 31 December 2020, whichever occurred first. Proportional hazards assumption was tested by evaluating the correlation between Schoenfeld residuals and follow-up time, and no evidence of violation was observed. Results were presented as hazard ratios (HR) and 95% confidence intervals (CI), using participants without night shift experience as the reference group. Two models were fitted: model 1 was adjusted for age at baseline; model 2 was adjusted for age at baseline, education, income level, BMI, smoking, alcohol consumption, physical activity and CHFP score. Night shift metrics were first analyzed on categorical scale. For continuous variables, including cumulative duration of night shift work and frequency of night shifts, tests for linear trend were performed by entering these variables as continuous forms in the Cox regression models. To evaluate potential nonlinear associations, restricted cubic splines with three knots (10th, 50th, 90th percentile) were applied to flexibly model the association between continuous night shift metrics and cancer risk among ever-night shift participants. Lagged analyses were conducted for night shift work duration by removing the most recent 5, 10, 15 and 20 years of night shift work exposure (fixing exposure to 5, 10, 15 and 20 years prior to baseline) to identify the long-term exposure contributed to cancer risk (26).

To examine the robustness of primary findings, sensitivity analyses were conducted. To minimize potential confounding from ongoing night shift work in the association between night shift work duration and cancer risk, we restricted the analysis to men who had ceased night shift work prior to baseline. For colorectal cancer and liver cancer, model 2 was further adjusted for a medical history of intestinal polyps and chronic hepatitis, respectively as they were strong risk factors for these cancers. However, these covariates were not retained in the final models because their inclusion neither changed the HR substantially nor improved the goodness of model fit (based on the Akaike information criterion, data not shown). To more accurately adjust smoking and alcohol consumption, categorical variables for the intensity of alcohol drinking (converted into ethanol intake per day) and the cumulative amount of cigarette smoking (defined as pack-year) were substituted for their binary forms in model 2, with each categorized as never-use or tertiles among users.

In addition, we performed prespecified exploratory analyses to evaluate whether lifestyle factors modified the associations between night shift metrics and cancer risk as recommended by IARC monographs on the identification of carcinogenic hazards to humans (4). We tested for interactions in the significant and robust associations by smoking, alcohol consumption, CHFP score, physical activity and BMI. Log-likelihood ratio tests were conducted to assess multiplicative interactions between night shift metrics and lifestyle factors by comparing the models with and without the cross-product terms. In another exploratory analysis, we examined the potential attenuation of cancer risk after cessation of night shift work. Ever night shift workers were categorized into three groups based on time since cessation: current workers, recent quitters (cessation ≤10 years) and long-term quitters (cessation >10 years). Each group was compared with never night shift workers using Cox regression models. We performed an additional analysis to evaluate the combined effects of duration and frequency on cancer risk. Participants were categorized into five mutually exclusive groups: never night shift (reference), short-term and low-intensity night shift (duration ≤10 years and frequency ≤8 nights/month); short-term and high-intensity night shift (duration ≤10 years and frequency >8 nights/month); long-term and low-intensity night shift (duration >10 years and frequency ≤8 nights/month); long-term and high-intensity night shift (duration >10 years and frequency >8 nights/month).

Statistical analyses were performed using SAS 9.4 (SAS Institute Inc, Cary, NC, USA). A two-tailed P-value <0.05 was considered statistically significant.

Results

During a median follow-up of 16.1 years, a total of 8202 incident cancer cases were documented. The site-specific incidence numbers are presented in supplementary figure S2. Among 61 078 participants, 20 942 men had night shift work experience. Compared to those without night shift work experience, individuals with a history of night shift work were younger at baseline, had a greater proportion of lower education and income level, and were likely to report ever smoking, ever alcohol consumption and abnormal body weight. They also reported higher levels of total physical activity and lower CHFP score (table 1).

Table 1

Characteristics of the study participants in the Shanghai Men’s Health Study (N=61 078). [CHFP=Chinese Food Pagoda; MET=metabolic equivalent of task; IQR=interquartile range]

  Night shift workers (N=20 942)   Non-night shift workers (N=40 136) P-value a
  N (%) Median (IQR)   N (%) Median (IQR)
Age (years)   52.46 (15.69)     53.45 (16.01) <0.0001
Education           <0.0001
  Elementary school or below 1779 (8.49)     2256 (5.62)    
  Middle school 8387 (40.05)     11 839 (29.50)    
  High school 7882 (37.64)     14 675 (36.56)    
  High profession, college or above 2894 (13.82)     11 366 (28.32)    
Income level b           <0.0001
  Low 3222 (15.39)     4468 (11.13)    
  Low to middle 10 039 (47.94)     16 008 (39.88)    
  Middle to high 6319 (30.17)     15 095 (37.61)    
  High 1362 (6.50)     4565 (11.37)    
Smoking           <0.0001
  Ever 15 548 (74.24)     26 989 (67.24)    
  Never 5394 (25.76)     13 147 (32.76)    
Alcohol consumption           <0.0001
  Ever 7883 (37.64)     12 706 (31.66)    
  Never 13 059 (62.36)     27 430 (68.34)    
Body mass index c           0.0268
  Underweight 937 (4.47)     1640 (4.09)    
  Normal 10 422 (49.77)     20 157 (50.22)    
  Overweight 7804 (37.26)     15 105 (37.63)    
  Obese 1779 (8.49)     3234 (8.06)    
Total physical activity (MET hours/week)   58.02 (45.23)     52.03 (43.26) <0.0001
CHFP score   30.28 (6.50)     31.19 (6.57) <0.0001

a Continuous variables were compared using Mann-Whitney U tests and categorical variables were compared using c2 test. b Personal income (yuan/month): low=<500; low to middle=500–999; middle to high=1000–1999; high=≥2,000. c BMI (kg/m2): underweight=<18.5; normal=18.5–<24.0; overweight=24.0–<28.0; obese=≥28.0.

Distributions of night shift work metrics between cancer and non-cancer groups are presented in supplementary figure S3. No statistically significant differences were observed between the cancer and non-cancer groups regarding age at starting night shift work or average monthly frequency of night shifts. A significant difference was found in the cumulative duration of night shift work (P=0.016).

In multivariable-adjusted models, none of the associations between night shift work experience and the risk of total or site-specific cancer reached statistical significance, except for kidney cancer (HR 0.77, 95% CI 0.60–0.99). However, since the upper confidence limit was close to null value, this association was not reliable for drawing substantive conclusions (table 2).

Table 2

Associations between night shift work experience and cancer risk among men. [HR=hazard ratio; CI=confidence interval.]

  Night shift work N cases/participants HR (95% CI) a HR (95% CI) b
All cancers Never 5375/40 136 1.00 (ref) 1.00 (ref)
    Ever 2827/20 942 1.05 (1.01–1.10) 1.01 (0.96–1.06)
Major cancer site
  Lung Never 1092/40 136 1.00 (ref) 1.00 (ref)
    Ever 645/20 942 1.18 (1.07–1.31) 1.05 (0.95–1.15)
  Colorectum Never 900/40 136 1.00 (ref) 1.00 (ref)
    Ever 503/20 942 1.13 (1.01–1.26) 1.10 (0.99–1.23)
  Liver Never 388/40 136 1.00 (ref) 1.00 (ref)
    Ever 204/20 942 1.04 (0.88–1.23) 0.96 (0.81–1.15)
  Stomach Never 581/40 136 1.00 (ref) 1.00 (ref)
    Ever 321/20 942 1.12 (0.97–1.28) 1.04 (0.91–1.20)
  Thyroid Never 96/40 136 1.00 (ref) 1.00 (ref)
    Ever 43/20 942 0.84 (0.59–1.21) 0.92 (0.64–1.33)
  Esophagus Never 121/40 136 1.00 (ref) 1.00 (ref)
    Ever 70/20 942 1.16 (0.86–1.55) 0.90 (0.67–1.21)
  Prostate c Never 618/39 950 1.00 (ref) 1.00 (ref)
    Ever 246/20 851 0.82 (0.71–0.95) 0.89 (0.76–1.03)
  Bladder Never 224/40 136 1.00 (ref) 1.00 (ref)
    Ever 102/20 942 0.92 (0.73–1.17) 0.92 (0.73–1.17)
  Pancreas Never 229/40 136 1.00 (ref) 1.00 (ref)
    Ever 117/20 942 1.04 (0.83–1.29) 1.03 (0.82–1.29)
  Kidney Never 235/40 136 1.00 (ref) 1.00 (ref)
    Ever 87/20 942 0.73 (0.57–0.93) 0.77 (0.60–0.99)

a Adjusted for age at baseline. b Adjusted for age at baseline, education, income, smoking, alcohol consumption, CHFP score, physical activity and body mass index. c An additional 277 participants with a history of prostatectomy at baseline were excluded.

Age at starting night shift work did not appear to be associated with the risk of cancer (table 3). Starting night shift work at an earlier age (≤30 years) only seems to be associated with kidney cancer risk (HR 0.73, 95% CI 0.55–0.98) in the multivariable adjusted model. However, the marginal significance did not guarantee a firm conclusion and should be interpreted with caution.

Table 3

Associations between age at starting night shift work and cancer risk among men. [HR=hazard ratio; CI=confidence interval.]

  Age at starting night shift work N cases/participants HR (95% CI) a HR (95% CI) b
All cancers None 5375/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 2022/14 746 1.05 (1.00–1.11) 1.01 (0.96–1.07)
    31–40 years old 367/3003 1.05 (0.94–1.16) 1.00 (0.90–1.11)
    >40 years old 438/3188 1.08 (0.98–1.19) 1.00 (0.91–1.10)
Major cancer site
  Lung None 1092/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 458/14 746 1.18 (1.06–1.31) 1.06 (0.95–1.18)
    31–40 years old 77/3003 1.06 (0.84–1.34) 0.93 (0.74–1.17)
    >40 years old 110/3188 1.33 (1.10–1.62) 1.07 (0.88–1.31)
  Colorectum None 900/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 361/14 746 1.13 (1.00–1.27) 1.11 (0.98–1.25)
    31–40 years old 60/3003 1.03 (0.79–1.34) 1.00 (0.77–1.31)
    >40 years old 82/3188 1.22 (0.97–1.53) 1.17 (0.93–1.48)
  Liver None 388/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 136/14 746 0.98 (0.80–1.19) 0.91 (0.75–1.11)
    31–40 years old 30/3003 1.12 (0.77–1.63) 1.04 (0.71–1.51)
    >40 years old 38/3188 1.27 (0.91–1.77) 1.13 (0.80–1.58)
  Stomach None 581/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 234/14 746 1.13 (0.97–1.32) 1.07 (0.91–1.24)
    31–40 years old 50/3003 1.35 (1.01–1.80) 1.25 (0.94–1.68)
    >40 years old 37/3188 0.86 (0.61–1.19) 0.76 (0.54–1.06)
  Thyroid None 96/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 33/14746 0.93 (0.62–1.37) 1.00 (0.67–1.50)
    31–40 years old 5/3003 0.63 (0.25–1.54) 0.70 (0.28–1.72)
    >40 years old 5/3188 0.67 (0.27–1.65) 0.76 (0.31–1.90)
  Esophagus None 121/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 47/14746 1.09 (0.78–1.52) 0.87 (0.62–1.23)
    31–40 years old 8/3003 0.99 (0.49–2.03) 0.76 (0.37–1.56)
    >40 years old 15/3188 1.63 (0.95–2.79) 1.10 (0.64–1.90)
  Prostate c None 618/39 949 1.00 (ref) 1.00 (ref)
    ≤30 years old 184/14 680 0.84 (0.71–0.99) 0.90 (0.76–1.06)
    31–40 years old 24/2994 0.65 (0.43–0.97) 0.69 (0.46–1.04)
    >40 years old 38/3172 0.89 (0.64–1.23) 1.02 (0.73–1.42)
  Bladder None 224/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 77/14746 0.97 (0.75–1.25) 0.97 (0.74–1.26)
    31–40 years old 14/3003 0.97 (0.57–1.67) 0.96 (0.56–1.65)
    >40 years old 11/3188 0.66 (0.36–1.21) 0.67 (0.36–1.23)
  Pancreas None 229/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 98/14 746 1.13 (0.89–1.44) 1.12 (0.88–1.44)
    31–40 years old 11/3003 0.75 (0.41–1.37) 0.74 (0.40–1.36)
    >40 years old 14/3188 0.82 (0.48–1.42) 0.81 (0.47–1.39)
  Kidney None 235/40 135 1.00 (ref) 1.00 (ref)
    ≤30 years old 59/14 746 0.70 (0.52–0.93) 0.73 (0.55–0.98)
    31–40 years old 18/3003 1.08 (0.67–1.74) 1.16 (0.71–1.87)
    >40 years old 10/3188 0.54 (0.29–1.03) 0.59 (0.31–1.12)

a Adjusted for age at baseline. b Adjusted for age at baseline, education, income, smoking, alcohol consumption, Chinese food pagoda score, physical activity and body mass index. c An additional 277 participants with a history of prostatectomy at baseline were excluded.

Analysis of cumulative duration of night shift work revealed a positive association between 11–20 years of night shift work and pancreatic cancer risk (HR 1.59, 95% CI 1.09–2.31) after multivariable adjustments for potential confounders (table 4). No significant linear trends were observed between cumulative duration of night shift work and all cancers combined or major site-specific cancers in the multivariable-adjusted models (all Ptrend >0.05). The exposure–hazard curve did not indicate any nonlinear associations (all Pnonlinear >0.05) (table 4). In lagged analyses, the association between 11–20 years of night shift work and pancreatic cancer risk remained statistically significant across all lag periods examined. The HR exhibited a generally increasing trend with longer lag intervals (5 years: 1.52; 10 years: 1.61; 15 years: 1.82), followed by slight attenuation in the 20-year lagged analysis, though the association remained significant (figure 1, supplementary table S1).

Table 4

Associations between cumulative duration of night shift work and cancer risk in men. [HR=hazard ratio; CI=confidence interval.]

  Cumulative duration of night shift work N
cases/participants
HR (95% CI) a HR (95% CI) b Ptrend c Pnonlinear d
All cancers None 5375/40 135 1.00 (ref) 1.00 (ref) 0.4020 0.6083
    ≤10 years 1827/13 879 1.04 (0.98–1.10) 1.01 (0.95–1.06)
    11–20 years 510/3959 1.07 (0.97–1.17) 1.01 (0.92–1.11)
    >20 years 490/3099 1.11 (1.01–1.21) 1.04 (0.95–1.14)
Major cancer site
  Lung None 1092/40 135 1.00 (ref) 1.00 (ref) 0.5674 0.6969
    ≤10 years 361/11 493 1.16 (1.04–1.30) 1.05 (0.94–1.17)
    11–20 years 116/3959 1.19 (0.98–1.44) 1.02 (0.84–1.24)
    >20 years 112/3099 1.27 (1.05–1.55) 1.06 (0.87–1.30)
  Colorectum None 900/40 135 1.00 (ref) 1.00 (ref) 0.1063 0.3405
    ≤10 years 292/11 493 1.11 (0.98–1.26) 1.09 (0.96–1.24)
    11–20 years 84/3959 1.06 (0.85–1.33) 1.03 (0.82–1.29)
    >20 years 94/3099 1.26 (1.02–1.56) 1.22 (0.98–1.52)
  Liver None 388/40 135 1.00 (ref) 1.00 (ref) 0.6038 0.7515
    ≤10 years 104/11 493 1.03 (0.84–1.25) 0.97 (0.79–1.18)
    11–20 years 37/3959 1.03 (0.74–1.44) 0.94 (0.67–1.32)    
    >20 years 34/3099 1.11 (0.78–1.58) 0.98 (0.69–1.41)    
  Stomach None 581/40 135 1.00 (ref) 1.00 (ref) 0.5680 0.7529
    ≤10 years 191/11 493 1.12 (0.96–1.31) 1.06 (0.90–1.24)
    11–20 years 63/3959 1.25 (0.96–1.62) 1.14 (0.88–1.48)
    >20 years 48/3099 0.98 (0.73–1.31) 0.89 (0.66–1.20)
  Thyroid None 96/40 135 1.00 (ref) 1.00 (ref) 0.6745 0.266
    ≤10 years 25/11 493 0.84 (0.55–1.27) 0.91 (0.60–1.38)
    11–20 years 5/3959 0.50 (0.20–1.22) 0.56 (0.23–1.37)
    >20 years 9/3099 1.40 (0.71–2.79) 1.62 (0.80–3.25)
  Esophagus None 121/40 135 1.00 (ref) 1.00 (ref) 0.3010 0.1448
    ≤10 years 28/11 493 0.95 (0.66–1.37) 0.78 (0.54–1.12)
    11–20 years 12/3959 1.10 (0.61–1.99) 0.83 (0.46–1.51)
    >20 years 20/3099 2.04 (1.27–3.29) 1.40 (0.86–2.28)
  Prostatee None 618/39 949 1.00 (ref) 1.00 (ref) 0.4313 0.9342
    ≤10 years 163/13 820 0.84 (0.71–1.00) 0.89 (0.75–1.06)
    11–20 years 36/3943 0.71 (0.51–1.00) 0.78 (0.56–1.10)
    >20 years 47/3083 0.85 (0.63–1.14) 0.96 (0.71–1.30)
  Bladder None 224/40 135 1.00 (ref) 1.00 (ref) 0.3487 0.6238
    ≤10 years 60/11 493 0.94 (0.72–1.23) 0.94 (0.71–1.23)
    11–20 years 20/3959 1.03 (0.65–1.62) 1.01 (0.64–1.61)
    >20 years 14/3099 0.75 (0.44–1.29) 0.77 (0.44–1.32)
  Pancreas None 229/40 135 1.00 (ref) 1.00 (ref) 0.7441 0.1411
    ≤10 years 64/11 493 0.95 (0.73–1.24) 0.94 (0.72–1.24)
    11–20 years 32/3959 1.61 (1.11–2.34) 1.59 (1.09–2.31)
    >20 years 15/3099 0.78 (0.46–1.32) 0.77 (0.46–1.31)
  Kidney None 235/40 135 1.00 (ref) 1.00 (ref) 0.6651 0.8635
    ≤10 years 50/11 493 0.70 (0.52–0.94) 0.74 (0.55–1.00)
    11–20 years 14/3959 0.63 (0.37–1.08) 0.68 (0.39–1.17)
    >20 years 17/3099 0.95 (0.58–1.55) 1.02 (0.62–1.68)
a Adjusted for age at baseline.
b Adjusted for age at baseline, education, income, smoking, alcohol consumption, Chinese food pagoda score, physical activity and body mass index.
c Modeled as a continuous variable to test for linear trend.
d Nonlinear associations were tested among participants with a history of night shift work.
e An additional 277 participants with a history of prostatectomy at baseline were excluded.
Figure 1

Associations between cumulative duration of night shift work and pancreatic cancer risk across 5-, 10-, 15- and 20-year lag periods. Hazard ratios and 95% confidence intervals are shown for (A) ≤10, (B) 11–20, and (C) >20 years of cumulative duration, using never night shift participants as the reference group.

SJWEH-52-391-g001.tif

Although the age-adjusted model suggested that frequency of night shifts was associated with risk for total and some site-specific cancers, multivariable adjustment attenuated this association to non-significant (table 5). No significant linear trends (all Ptrend >0.05) or non-linear associations (all Pnonlinear >0.05) were observed between shift frequency and cancer risks after multivariable adjustment (table 5).

Table 5

Associations between frequency of night shifts and cancer risk in men. [HR=hazard ratio; CI=confidence interval.]

  Average monthly frequency of night shifts N
cases/participants
HR (95% CI) a HR (95% CI) b Ptrend c Pnonlinear d
All cancers None 5375/40 135 1.00 (ref) 1.00 (ref) 0.2522 0.5089
    ≤8 nights/month 1900/14 390 1.02 (0.97–1.08) 0.98 (0.93–1.04)
    >8 nights/month 927/6548 1.13 (1.05–1.21) 1.06 (0.99–1.14)
Major cancer site
  Lung None 1092/40 135 1.00 (ref) 1.00 (ref) 0.0798 0.0602
    ≤8 nights/month 422/14 390 1.12 (1.00–1.26) 1.00 (0.89–1.12)
    >8 nights/month 223/6548 1.33 (1.15–1.53) 1.14 (0.98–1.31)
  Colorectum None 900/40 135 1.00 (ref) 1.00 (ref) 0.1526 0.9845
    ≤8 nights/month 340/14 390 1.10 (0.97–1.25) 1.08 (0.95–1.23)
    >8 nights/month 163/6548 1.19 (1.01–1.41) 1.15 (0.97–1.37)
  Liver None 388/40 135 1.00 (ref) 1.00 (ref) 0.7409 0.3739
    ≤8 nights/month 136/14 390 1.00 (0.83–1.22) 0.93 (0.77–1.14)
    >8 nights/month 68/6548 1.12 (0.86–1.45) 1.03 (0.79–1.33)
  Stomach None 581/40 135 1.00 (ref) 1.00 (ref) 0.3592 0.1091
    ≤8 nights/month 214/14 390 1.07 (0.92–1.26) 1.01 (0.86–1.18)
    >8 nights/month 107/6548 1.22 (0.99–1.50) 1.12 (0.91–1.38)
  Thyroid None 96/40 135 1.00 (ref) 1.00 (ref) 0.9827 0.4992
    ≤8 nights/month 27/14 390 0.77 (0.51–1.19) 0.85 (0.55–1.31)
    >8 nights/month 16/6548 0.98 (0.58–1.67) 1.08 (0.63–1.84)
  Esophagus None 121/40 135 1.00 (ref) 1.00 (ref) 0.7977 0.5329
    ≤8 nights/month 43/14 390 1.03 (0.73–1.46) 0.82 (0.57–1.16)
    >8 nights/month 27/6548 1.45 (0.95–2.20) 1.07 (0.70–1.63)
  Prostatee None 618/39 949 1.00 (ref) 1.00 (ref) 0.1514 0.9132
    ≤8 nights/month 163/14 318 0.78 (0.66–0.93) 0.84 (0.70–1.00)
    >8 nights/month 83/6529 0.92 (0.73–1.15) 1.00 (0.79–1.26)
  Bladder None 224/40 135 1.00 (ref) 1.00 (ref) 0.9944 0.2766
    ≤8 nights/month 70/14 390 0.91 (0.70–1.19) 0.91 (0.70–1.20)
    >8 nights/month 32/6548 0.95 (0.65–1.37) 0.94 (0.65–1.37)
  Pancreas None 229/40 135 1.00 (ref) 1.00 (ref) 0.8673 0.2356
    ≤8 nights/month 81/14 390 1.03 (0.80–1.33) 1.03 (0.79–1.33)
    >8 nights/month 36/6548 1.04 (0.73–1.48) 1.03 (0.72–1.46)
  Kidney None 235/40 135 1.00 (ref) 1.00 (ref) 0.1026 0.2262
    ≤8 nights/month 61/14 390 0.74 (0.56–0.98) 0.79 (0.59–1.05)
    >8 nights/month 26/6548 0.69 (0.46–1.04) 0.73 (0.49–1.10)
a Adjusted for age at baseline.
b Adjusted for age at baseline, education, income, smoking, alcohol consumption, Chinese food pagoda score, physical activity and body mass index.
c Modeled as a continuous variable to test for linear trend.
d Nonlinear associations were tested among participants with a history of night shift work.
e An additional 277 participants with a history of prostatectomy at baseline were excluded.

The results of the sensitivity analyses largely corroborated the primary findings (supplementary table S2–S7). Following a conservative approach that excluded associations which were non-significant, of marginal significance, or unrobust, only the association between cumulative duration of night shift work and pancreatic cancer risk was retained for assessment of effect modification. Log-likelihood ratio tests did not indicate interactions between cumulative duration of night shift work and any lifestyle factors examined (all P >0.05) (supplementary figure S4). In an exploratory analysis examining the potential attenuation of risk after cessation of night shift work, some site-specific associations between certain night shift metrics and cancer risk were recognized, although these associations were observed only in specific cessation subgroups rather than consistently across all cessation categories. These findings do not support a clear interpretation of risk attenuation after cessation of night shift work (supplementary table S8–S10). In analysis examining the combined effects of night shift work duration and frequency, no statistically significant associations were observed between any of the four exposure groups and total or major site-specific cancer risk (supplementary table S11).

Discussion

In this large-scale prospective cohort study among Chinese men, we found an increased risk of pancreatic cancer for participants with 11–20 years of cumulative night shift work, compared to those who never engaged in night shift work. No significant associations were found for other night shift work metrics, including night shift work experience, age at starting, cumulative duration, or frequency in relation to the risk of overall cancer or other major site-specific cancers.

This study did not observe the significant associations between night shift work metrics and the risk of overall cancer or some common cancers. The null finding for overall cancer is consistent with previous studies conducted in Japanese (27) and German (28) populations. However, the results for certain common cancers appear to differ from the 2019 IARC evaluation, which concluded that positive associations have been observed between night shift work and cancers of the breast, prostate, colon, and rectum (4). The biological plausibility of these associations is supported by shared mechanisms, including melatonin disruption (29), alterations in clock gene expression (30), and impaired immune function (31), as well as cancer-specific pathways such as sex hormone signaling in breast (32) and prostate (33) cancers and gut microbiome disruption in colorectal cancer (34). Notably, evidence from prospective studies published after the 2019 IARC evaluation regarding these cancers remains inconsistent, with both positive and null associations reported for breast (5), prostate (6, 7), and colorectal cancers (8, 9). Population heterogeneity in the capacity of maintaining a normal circadian pattern (35) and inconsistent definitions of exposure (12) may be critical factors that explain inconsistent findings across studies. For cancer sites other than those specified by IARC, although positive associations for some night shift work metrics were observed in cancers of lung (36), esophagus (27), thyroid (37), bladder (38), among others, these risks were not consistently seen across the body of evidence (3944). Overall, the existing evidence for these cancer outcomes remains preliminary and contradictory.

This study suggests that cumulative night shift work may be associated with an increased risk of pancreatic cancer, although a statistically significant association was observed only for intermediate-to-long-term exposure duration (11–20 years). Short-term exposure (≤10 years) may indicate a potential risk-accumulation phase where the exposure has not yet reached the threshold necessary to significantly alter cancer risk. Conversely, the non-significant association for long-term exposure (>20 years) may reflect the influence of the healthy worker effect (45). The significant association identified specifically for the 11–20 years exposure window potentially represents a critical etiologically relevant period for carcinogenesis. This duration may be sufficient for chronic circadian disruption, through mechanisms such as suppression of melatonin and dysregulation of clock genes, to cause cumulative damage to metabolic and cellular repair processes, thereby reaching a threshold that significantly promotes cancer development (4648).

Our finding of a positive association between 11–20 years of cumulative night shift work and pancreatic cancer risk contributes to the mixed body of evidence on this topic, which includes both supportive and null results. A case–control study of men in Canada reported that ever performing night shift work was associated with a 127% higher risk of pancreatic cancer [odds ratio (OR) 2.27, 95% CI 1.24–4.15] (49). Suggestive elevations in risk – greater than twofold – were also observed for durations of 5–10 and >10 years of cumulative night shift work, with wide CI rendering these estimates statistically non-significant and imprecise (50). It is important to note that the available cohort evidence has generally been limited by a lack of detailed metrics of night shift work (such as cumulative duration) and has largely reported null associations with pancreatic cancer (27, 28, 50, 51). Collectively, the current epidemiological evidence remains inconclusive, highlighting the need for further prospective studies with refined night shift work assessment to clarify this association.

Despite the lack of epidemiological consensus, a biologically plausible link between night shift work and pancreatic cancer risk is supported by the melatonin hypothesis (29). This hypothesis establishes a mechanistic link between circadian disruption – particularly night shift work – and cancer risk by proposing that light at night suppresses nocturnal melatonin production, diminishing its anticancer properties. Melatonin protects against pancreatic carcinogenesis through multiple pathways (52): it confers protection against inflammatory damage and oxidative stress in the pancreas by enhancing antioxidant enzyme activity and scavenging reactive oxygen and nitrogen species; it also reduces endothelial cell proliferation and angiogenesis through inhibition of vascular endothelial growth factor; low levels of melatonin promote the expression of anti-apoptotic heat shock proteins, thereby blocking caspase-3 activation and inhibiting apoptosis. Collectively, disruption of melatonin signaling due to light at night compromises the protective network, potentially facilitating the biological processes of pancreatic cancer, including chronic inflammation, uncontrolled proliferation, and resistance to cell death. In addition to the melatonin pathway, night shift work has also been shown to disrupt the circadian rhythmicity of DNA repair genes and elevate DNA damage among humans, providing a direct genotoxic mechanism linking circadian disruption to carcinogenic risk (53). Besides, night shift work disrupts circadian rhythms in pancreatic islets, leading to impaired insulin secretion, insulin resistance, and glucose intolerance (54). This establishes a hyperglycemic metabolic environment that predisposes to type 2 diabetes mellitus, a well-established risk factor that significantly elevates the incidence of pancreatic cancer (55). Together, these mechanisms offer complementary biological rationales supporting a potential association between night shift work and pancreatic carcinogenesis.

The positive association between 11–20 years of night shift work and pancreatic cancer risk remained robust across all sensitivity analyses. Notably, this association exhibited a generally increasing trend with longer lag intervals, specifically over the 5-, 10-, and 15-year lag periods. Although slight attenuation was observed at the 20-year lag compared to the preceding increasing trend, the association remained statistically significant. These results are similar to those from a previously mentioned case–control study conducted among Canadian men, which reported a markedly elevated risk of pancreatic cancer associated with night shift work performed ≤20 years prior to diagnosis or interview (OR 3.81, 95% CI 1.75–8.28), along with a weaker, non-significant increase in risk for night work conducted >20 years prior to diagnosis or interview (OR 1.49, 95% CI 0.55–4.06) (49). Both studies suggest a lag effect of night shift work, indicating that past exposure dating back as far as 20 years prior to baseline or diagnosis may still contribute to cancer risk. In the present study, the strengthening association with earlier exposure windows, peaking at around 15-year lag, indicates that night shift work exerts a long-term effect on pancreatic cancer risk, with a prolonged induction or latency period of over a decade.

This prospective cohort study provided a comprehensive assessment of the association between night shift work and cancer risk, utilizing detailed shift work metrics and examining incidence across ten major cancer sites as well as all cancers combined in the Chinese men. The study extends previous research by incorporating underreported exposure details, investigating seldom-explored non-linear dose–response associations for key metrics, employing lagged analyses to account for long-term contribution of past exposure, and evaluating potential effect modification by lifestyle factors. Several limitations should be considered when interpreting our findings. First, night shift exposure assessments were derived exclusively from self-reported questionnaires at baseline, which was susceptible to recall bias and did not capture dynamic changes over time. This may have led to non-differential misclassification of exposure, which likely biases our effect estimates toward the null. Consequently, the true associations between night shift work and cancer risk in this population may be stronger than those observed. Future studies with repeated, longitudinal exposure assessments are warranted to better characterize long-term exposure patterns and their associations with cancer risk. Second, while genetic polymorphisms in circadian rhythm genes were known to modulate physiological responses to night shifts and influence cancer susceptibility (56), the lack of genetic data precluded the examination of such gene-environment interactions. Third, detailed occupational histories were not available, thereby preventing control for potential confounding from workplace carcinogens that frequently co-occur with night shift work in certain industries (57, 58). Finally, although we adjusted for a range of available confounders, residual confounding due to unmeasured or unknown factors cannot be ruled out, as is inherent in observational studies (59).

Concluding remarks

In conclusion, this large-scale prospective cohort study of Chinese men found no significant association for night shift work metrics and the risk of overall cancer or some common cancers. But there is a significant association between intermediate-to-long-term (11–20 years) cumulative night shift work and an increased risk of pancreatic cancer. These results provided robust epidemiological findings from an understudied population and refined our understanding of the carcinogenic potential of this common occupational exposure.

Acknowledgments

We thank all participants and staff from SMHS for their contribution to this research.

Funding

This work was supported by the National Key Project of Research and Development Program of China [2021YFC2500404], Shanghai Anticancer Association EYAS Project [SACA-CY23C03], and the subcontracts from grant of the US National Institutes of Health [UM1 CA173640] for the parent cohort. All funders had no role in the design, analysis or writing of this article.

Conflict of interest

The authors declare no conflicts of interest.

Protection of research participants

This study was carried out in accordance with Declaration of Helsinki. The Institutional Review Boards of the Shanghai Cancer Institute and Vanderbilt University approved the cohort protocol. The Renji Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine (KY2024-050-C) approved the study.

Informed consent

Informed consent was obtained from all subjects at baseline.

References

1 

International Labor Organization. Working time and work-life balance around the world [Internet]. 2023 [cited 2025 December 24]. Available from: https://www.ilo.org/publications/working-time-and-work-life-balance-around-world

2 

Zeng XQ, Liang L, Idris SU. Working time in transition: the dual task of standardization and flexibilization in China. Geneva: International Labor Office; 2005. 21p.

3 

Finger AM, Kramer A. Mammalian circadian systems: organization and modern life challenges. Acta Physiol (Oxf) 2021 Mar;231(3):e13548. [CrossRef] [PubMed]

4 

International Agency for Research on Cancer. Night shift work. IARC Monographs on the identification of carcinogenic hazards to humans [Internet]. 2019 [cited 2025 December 24]. Available from: https://publications.iarc.who.int/593

5 

Hansen J, Pedersen JE. Night shift work and breast cancer risk - 2023 update of epidemiologic evidence. J Natl Cancer Cent 2024 Sep;5(1):94–103. [CrossRef] [PubMed]

6 

Berge LA, Liu FC, Grimsrud TK, Babigumira R, Støer NC, Kjærheim K et al. Night shift work and risk of aggressive prostate cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort. Int J Epidemiol 2023 Aug;52(4):1003–14. [CrossRef] [PubMed]

7 

Yang G, Yang Y, Lv K, Wu Y, Song T, Yuan Q. Night shift work and prostate cancer: a large cohort study from UK Biobank and Mendelian randomisation study. BMJ Open 2024 Dec;14(12):e084401. [CrossRef] [PubMed]

8 

Shi Y, Liu L, Hamada T, Nowak JA, Giannakis M, Ma Y et al. Night-shift work duration and risk of colorectal cancer according to IRS1 and IRS2 expression. Cancer Epidemiol Biomarkers Prev 2020 Jan;29(1):133–40. [CrossRef] [PubMed]

9 

Wichert K, Rabstein S, Stang A, Erbel R, Eisele L, Arendt M et al. Associations between shift work and risk of colorectal cancer in two German cohort studies. Chronobiol Int 2020 Aug;37(8):1235–43. [CrossRef] [PubMed]

10 

Wegrzyn LR, Tamimi RM, Rosner BA, Brown SB, Stevens RG, Eliassen AH et al. Rotating night-shift work and the risk of breast cancer in the nurses’ health studies. Am J Epidemiol 2017 Sep;186(5):532–40. [CrossRef] [PubMed]

11 

Åkerstedt T, Knutsson A, Narusyte J, Svedberg P, Kecklund G, Alexanderson K. Night work and breast cancer in women: a Swedish cohort study. BMJ Open 2015 Apr;5(4):e008127. [CrossRef] [PubMed]

12 

Travis RC, Balkwill A, Fensom GK, Appleby PN, Reeves GK, Wang XS et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst 2016 Oct;108(12):djw169. [CrossRef] [PubMed]

13 

Papantoniou K, Hansen J. Cohort studies versus case-control studies on night-shift work and cancer risk: the importance of exposure assessment. Am J Epidemiol 2024 Apr;193(4):577–9. [CrossRef] [PubMed]

14 

Kwon P, Lundin J, Li W, Ray R, Littell C, Gao D et al. Night shift work and lung cancer risk among female textile workers in Shanghai, China. J Occup Environ Hyg 2015;12(5):334–41. [CrossRef] [PubMed]

15 

Li A, Shen Z, Sun Z, Yun S, Tian X, Hu Z et al. Occupational risk factors and breast cancer in Beijing, China: a hospital-based case-control study. BMJ Open 2022 Feb;12(2):e054151. [CrossRef] [PubMed]

16 

Li W, Ray RM, Thomas DB, Davis S, Yost M, Breslow N et al. Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control 2015 Jan;26(1):143–50. [CrossRef] [PubMed]

17 

Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 2010 May;171(9):953–9. [CrossRef] [PubMed]

18 

Tse LA, Lee PM, Ho WM, Lam AT, Lee MK, Ng SS et al. Bisphenol A and other environmental risk factors for prostate cancer in Hong Kong. Environ Int 2017 Oct;107:1–7. [CrossRef] [PubMed]

19 

Wang P, Ren FM, Lin Y, Su FX, Jia WH, Su XF et al. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med 2015 Apr;16(4):462–8. [CrossRef] [PubMed]

20 

Yang W, Shi Y, Ke X, Sun H, Guo J, Wang X. Long-term sleep habits and the risk of breast cancer among Chinese women: a case-control study. Eur J Cancer Prev 2019 Jul;28(4):323–9. [CrossRef] [PubMed]

21 

Shu XO, Li H, Yang G, Gao J, Cai H, Takata Y et al. Cohort Profile: The Shanghai Men’s Health Study. Int J Epidemiol 2015 Jun;44(3):810–8. [CrossRef] [PubMed]

22 

Wang H, Zhai F. Programme and policy options for preventing obesity in China. Obes Rev 2013 Nov;14(0 2 Suppl 2):134–40. [CrossRef].

23 

Jurj AL, Wen W, Xiang YB, Matthews CE, Liu D, Zheng W et al. Reproducibility and validity of the Shanghai Men’s Health Study physical activity questionnaire. Am J Epidemiol 2007 May;165(10):1124–33. [CrossRef] [PubMed]

24 

Villegas R, Yang G, Liu D, Xiang YB, Cai H, Zheng W et al. Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men’s health study. Br J Nutr 2007 May;97(5):993–1000. [CrossRef] [PubMed]

25 

Yu D, Zhang X, Xiang YB, Yang G, Li H, Gao YT et al. Adherence to dietary guidelines and mortality: a report from prospective cohort studies of 134,000 Chinese adults in urban Shanghai. Am J Clin Nutr 2014 Aug;100(2):693–700. [CrossRef] [PubMed]

26 

Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Third edition. Philadelphia: Lippincott Williams & Wilkins, 2008. 301p.

27 

Arafa A, Eshak ES, Iso H, Muraki I, Tamakoshi A. Night work, rotating shift work, and the risk of cancer in japanese men and women: the JACC Study. J Epidemiol 2021 Dec;31(12):585–92. [CrossRef] [PubMed]

28 

Yong M, Blettner M, Emrich K, Nasterlack M, Oberlinner C, Hammer GP. A retrospective cohort study of shift work and risk of incident cancer among German male chemical workers. Scand J Work Environ Health 2014 Sep;40(5):502–10. [CrossRef] [PubMed]

29 

Stevens RG, Davis S. The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect. 1996 Mar;104 Suppl 1(Suppl 1):135–40. [CrossRef].

30 

Fortin BM, Mahieu AL, Fellows RC, Kang Y, Lewis AN, Ead AS et al. The diverse roles of the circadian clock in cancer. Nat Cancer 2025 May;6(5):753–67. [CrossRef] [PubMed]

31 

Wu Y, Tao B, Zhang T, Fan Y, Mao R. Pan-cancer analysis reveals disrupted circadian clock associates with T cell exhaustion. Front Immunol 2019 Oct;10:2451. [CrossRef] [PubMed]

32 

Vivarelli S, Formica T, Puliatti Y, Spatari G, Fenga C. Night shift work and breast cancer: from etiopathology to precision risk analysis. NPJ Breast Cancer 2025 Dec;12(1):7. [CrossRef] [PubMed]

33 

Kaakour D, Fortin B, Masri S, Rezazadeh A. Circadian clock dysregulation and prostate cancer: a molecular and clinical overview. Clin Med Insights Oncol 2023 Nov;17:11795549231211521. [CrossRef] [PubMed]

34 

Fellows RC, Chun SK, Larson N, Fortin BM, Mahieu AL, Song WA et al. Disruption of the intestinal clock drives dysbiosis and impaired barrier function in colorectal cancer. Sci Adv 2024 Sep;10(39):eado1458. [CrossRef] [PubMed]

35 

Bhatti P, Mirick DK, Davis S. Racial differences in the association between night shift work and melatonin levels among women. Am J Epidemiol 2013 Mar;177(5):388–93. [CrossRef] [PubMed]

36 

Zheng X, Feng Y, He J, Zou X, Liang J, Wu X et al. Night shift work and lung cancer risk: a prospective cohort study with mediator analysis from the UK Biobank. Sleep 2025 Aug;48(8):zsaf159. [CrossRef] [PubMed]

37 

Kim YT, Sung C, Pang Y, Cha C. Exposure to radiation and thyroid cancer risk among young female nurses: longitudinal analysis from the Korea Nurses’ Health Study. JMIR Cancer 2025 Sep;11:e68037. [CrossRef] [PubMed]

38 

Haghayegh S, Liu Y, Zhang Y, Strohmaier S, Papantoniou K, Markt S et al. Rotating night shift work and bladder cancer risk in women: results of two prospective cohort studies. Int J Environ Res Public Health 2023 Jan;20(3):2202. [CrossRef] [PubMed]

39 

Dun A, Zhao X, Jin X, Wei T, Gao X, Wang Y et al. Association between night-shift work and cancer risk: updated systematic review and meta-analysis. Front Oncol 2020 Jun;10:1006. [CrossRef] [PubMed]

40 

Cordina-Duverger E, Uchai S, Tvardik N, Billmann R, Martin D, Trédaniel J et al.; Welca Study Group. Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study). Int J Environ Res Public Health 2022 Dec;19(23):16246. [CrossRef] [PubMed]

41 

Schernhammer ES, Feskanich D, Liang G, Han J. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol 2013 Nov;178(9):1434–41. [CrossRef] [PubMed]

42 

Kwon P, Lundin J, Li W, Ray R, Littell C, Gao D et al. Night shift work and lung cancer risk among female textile workers in Shanghai, China. J Occup Environ Hyg 2015;12(5):334–41. [CrossRef] [PubMed]

43 

Gyarmati G, Turner MC, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J et al. Night shift work and stomach cancer risk in the MCC-Spain study. Occup Environ Med 2016 Aug;73(8):520–7. [CrossRef] [PubMed]

44 

Papantoniou K, Konrad P, Haghayegh S, Strohmaier S, Eliassen AH, Schernhammer E. Rotating night shift work, sleep, and thyroid cancer risk in the Nurses’ Health Study 2. Cancers (Basel) 2023 Nov;15(23):5673. [CrossRef] [PubMed]

45 

McMichael AJ. Standardized mortality ratios and the “healthy worker effect”: scratching beneath the surface. J Occup Med 1976 Mar;18(3):165–8. [CrossRef] [PubMed]

46 

Zheng T, Wang K, Shi Q, Zhang L, Yan Q, Jiang W et al. Clock genes in pancreatic disease progression: from circadian regulation to dysfunction. Ann Med 2025 Dec;57(1):2528449. [CrossRef] [PubMed]

47 

Clemente-Suarez VJ, Navarro-Jiménez E, Benitez-Agudelo JC, Beltrán-Velasco AI, Belinchón-deMiguel P, Ramos-Campo DJ et al. The multifaceted impact of circadian disruption on cancer risk: a systematic review of insights and economic implications. J Natl Cancer Cent 2025 Jun;5(5):524–36. [CrossRef] [PubMed]

48 

Cardenas-Romero S, Saderi N, Ramirez-Plascencia OD, Baez-Ruiz A, Flores-Sandoval O, Briones CE et al. Melatonin prevents tumor growth: the role of genes controlling the circadian clock, the cell cycle, and angiogenesis. J Pineal Res 2025 Jul;77(4):e70064. [CrossRef] [PubMed]

49 

Parent MÉ, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am J Epidemiol 2012 Nov;176(9):751–9. [CrossRef] [PubMed]

50 

Freeman JR, Saint-Maurice PF, Zhang T, Matthews CE, Stolzenberg-Solomon RZ. Sleep and risk of pancreatic cancer in the UK Biobank. Cancer Epidemiol Biomarkers Prev 2024 Apr;33(4):624–7. [CrossRef] [PubMed]

51 

Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007 Oct;33(5):336–43. [CrossRef] [PubMed]

52 

Gong YQ, Hou FT, Xiang CL, Li CL, Hu GH, Chen CW. The mechanisms and roles of melatonin in gastrointestinal cancer. Front Oncol 2022 Dec;12:1066698. [CrossRef] [PubMed]

53 

Koritala BS, Porter KI, Arshad OA, Gajula RP, Mitchell HD, Arman T et al. Night shift schedule causes circadian dysregulation of DNA repair genes and elevated DNA damage in humans. J Pineal Res 2021 Apr;70(3):e12726. [CrossRef] [PubMed]

54 

Zheng T, Wang K, Shi Q, Zhang L, Yan Q, Jiang W et al. Clock genes in pancreatic disease progression: from circadian regulation to dysfunction. Ann Med 2025 Dec;57(1):2528449. [CrossRef] [PubMed]

55 

Hua X, Fu R, Yin Z, Gong H. Association between diabetes duration and risk of pancreatic cancer: a meta-analysis of observational studies. Eur J Gastroenterol Hepatol 2026 Feb;38(2):124–31. [CrossRef] [PubMed]

56 

Ciarleglio CM, Ryckman KK, Servick SV, Hida A, Robbins S, Wells N et al. Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms 2008 Aug;23(4):330–40. [CrossRef] [PubMed]

57 

Jay SM, Gander PH, Eng A, Cheng S, Douwes J, Ellison-Loschmann L et al. New Zealanders working non-standard hours also have greater exposure to other workplace hazards. Chronobiol Int 2017;34(4):519–26. [CrossRef] [PubMed]

58 

Pepłońska B, Burdelak W, Bukowska A, Krysicka J, Konieczko K. Night shift work characteristics and occupational co-exposures in industrial plants in Łódź, Poland. Int J Occup Med Environ Health 2013 Aug;26(4):522–34. [CrossRef] [PubMed]

59 

Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol 2007 Sep;166(6):646–55. [CrossRef] [PubMed]


Additional material